Hypertonic glucose pleurodesis for preterm neonates with chylothorax.

Autor: Hon KLE; Department of Paediatrics, CUHKMC, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China., Hui CMP; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China., Fung GPG; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China., Leung KKY; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China., Yung TC; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China.
Jazyk: angličtina
Zdroj: Pediatric pulmonology [Pediatr Pulmonol] 2023 Jul; Vol. 58 (7), pp. 2145-2150. Date of Electronic Publication: 2023 May 12.
DOI: 10.1002/ppul.26436
Abstrakt: Chylothorax is a known complication of postcardiac surgery and the most common cause of pleural effusion in neonates. Conservative management is usually adopted, including Nil-per-Oral (NPO), treatment of underlying etiology of infection, and use of octreotide. Chylothorax resistant to medical therapy and drainage is often treated by chemical pleurodesis. Previously used pleurodesis agents have included talc, minocycline, OK-432, bleomycin, and povidone-iodine. 50% Dextrose (D50) has been reported to be useful for pleurodesis in adults. We successfully managed two cases of prematurely born infants with D50 as an alternative chemical sclerosant for chemical pleurodesis in a resistant chylothorax and discussed evidence of its use in the literature.
(© 2023 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: